JPM: Can we take J.P. Morgan out of San Francisco? We’re virtually there
This year’s virtual J.P. Morgan healthcare conference was a departure. For some, it was a regular week of now-normal working from home, just with more meetings. For others, their J.P. […]
China Showcase 2021 Highlights Trends and Areas Ripe for Investment
Biotech growth in China continued at a rapid pace in 2020, despite COVID-19, which emerged from that country to become a global pandemic. Opportunities in China remain good and are expected […]
Even in a virtual JPM week, we need to maintain the relationship ‘glue’ that keeps the biotech industry strong
Every January, the week of the annual J.P. Morgan Healthcare Conference (JPM week) is a whirlwind — oftentimes in the literal sense, with players from across the life science industry […]
COVID-19 to have long-lasting effect on biotech industry
The COVID-19 pandemic will have a widespread and long-lasting effect on the biotechnology industry, according to speakers at a January 5 presentation held in advance of the Biotech Showcase virtual […]
Top Operation Warp Speed official shares lessons learned from COVID-19
January 6, 2021 — The global COVID-19 pandemic has placed an urgent burden on governments to serve society, and with the help of the biotechnology and pharmaceutical industries, the job is […]
Bioscience and Healthcare of the Future: Overrun by Choices, Changes and Opportunities
“The future will be overrun by an army of new choices and changes in attitudes towards one’s own health. That creates a whole new area for bioscience and health, and […]
SARS-CoV-2 Causes Heart Damage in 20% of People with Mild or No COVID-19 Symptoms
COVID-19 is a cardiac condition as much as it is a pulmonary or respiratory disease. This knowledge is so recent that it often is overlooked by non-cardiologists, according to physicians […]
Bioelectric Medicine Ready for Prime Time as Companies Advance Therapies
Bioelectric medicine is coming into its own as a combination or stand-alone therapy for a growing cohort of conditions. Big pharma has funded programs, international coalitions have formed and the […]
SPACs Soar as Fast, Hassle-Free IPO Alternatives for Biotech Companies
Special purpose acquisition companies (SPACs) are resurging as a virtually hassle-free alternative to initial public offerings (IPOs). They’ve been around for years, but are just now becoming a factor for […]
FDA Deputy Commissioner Discusses Modernization Strategies for Data and Trials
The fusion of technology is blurring the lines between physical, biological and digital sciences, creating new ways of working, and new ways of designing, testing and analyzing drug candidates. The […]